FI960749A0 - A new oral pharmaceutical pharmaceutical containing progesterone and polyethylene glucose together with a carrier - Google Patents

A new oral pharmaceutical pharmaceutical containing progesterone and polyethylene glucose together with a carrier

Info

Publication number
FI960749A0
FI960749A0 FI960749A FI960749A FI960749A0 FI 960749 A0 FI960749 A0 FI 960749A0 FI 960749 A FI960749 A FI 960749A FI 960749 A FI960749 A FI 960749A FI 960749 A0 FI960749 A0 FI 960749A0
Authority
FI
Finland
Prior art keywords
pharmaceutical
carrier
new oral
containing progesterone
glucose together
Prior art date
Application number
FI960749A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI960749A (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI960749A0 publication Critical patent/FI960749A0/en
Publication of FI960749A publication Critical patent/FI960749A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FI960749A 1993-08-20 1996-02-19 A new oral pharmaceutical pharmaceutical containing progesterone and polyethylene glucose together with a carrier FI960749A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (en) 1993-08-20 1993-08-20 PHARMACEUTICAL FORMULA CONTAINING A HORMON
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (2)

Publication Number Publication Date
FI960749A0 true FI960749A0 (en) 1996-02-19
FI960749A FI960749A (en) 1996-02-19

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960749A FI960749A (en) 1993-08-20 1996-02-19 A new oral pharmaceutical pharmaceutical containing progesterone and polyethylene glucose together with a carrier

Country Status (17)

Country Link
EP (1) EP0789560A1 (en)
JP (1) JPH09501682A (en)
KR (1) KR960703570A (en)
CN (1) CN1132478A (en)
AU (1) AU7530594A (en)
BR (1) BR9407306A (en)
CA (1) CA2169840A1 (en)
CZ (1) CZ42596A3 (en)
DK (1) DK95093D0 (en)
FI (1) FI960749A (en)
HU (1) HUT74167A (en)
LT (1) LT4043B (en)
NO (1) NO960653D0 (en)
NZ (1) NZ271617A (en)
PL (1) PL313113A1 (en)
SK (1) SK19396A3 (en)
WO (1) WO1995005807A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (en) * 1997-12-19 2001-03-09 Besins Iscovesco Lab PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
FR2775599B1 (en) * 1998-03-09 2001-08-17 Besins Iscovesco Lab PHARMACEUTICAL COMPOSITION BASED ON SYNTHESIS NATURAL PROGESTERONE AND OESTRADIOL AND PROCESS FOR PREPARING THE SAME
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (en) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト Medicinal combination of ethinylestradiol and drospirenone for use as a contraceptive
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (en) * 2000-12-18 2002-06-19 Licentia Oy Entero-coated pharmaceutical compositions and their preparation
AU2002242339A1 (en) * 2002-03-14 2003-09-29 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (en) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Application of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/media for lactose-free oral contraception
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (en) 2011-11-23 2021-09-02 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (en) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. NATURAL COMBINED HORMONE SUBSTITUTION COMPOSITIONS AND THERAPIES
BR112017027688A2 (en) 2015-06-22 2018-09-04 Lipocine Inc ORAL COMPOSITIONS CONTAINING 17- HYDROXYPROGESTERONE ESTER AND RELATED METHODS
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (en) 1976-11-30 1979-06-08 Besins Jean Louis NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CA2169840A1 (en) 1995-03-02
DK95093D0 (en) 1993-08-20
NO960653L (en) 1996-02-19
AU7530594A (en) 1995-03-21
KR960703570A (en) 1996-08-31
LT4043B (en) 1996-09-25
PL313113A1 (en) 1996-06-10
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
HU9600376D0 (en) 1996-04-29
HUT74167A (en) 1996-11-28
BR9407306A (en) 1996-10-08
NZ271617A (en) 1996-11-26
FI960749A (en) 1996-02-19
WO1995005807A1 (en) 1995-03-02
NO960653D0 (en) 1996-02-19
JPH09501682A (en) 1997-02-18
LT96010A (en) 1996-06-25
CZ42596A3 (en) 1996-06-12
CN1132478A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
FI960749A0 (en) A new oral pharmaceutical pharmaceutical containing progesterone and polyethylene glucose together with a carrier
FI943570A0 (en) 1-Benzenesulfonyl-1,3-dihydroindole-2-undivate, their preparation and drugs containing them
DE3688532D1 (en) PHARMACEUTICAL PHARMACEUTICAL FORM WITH DELAYED DELIVERY.
FI954098A (en) Dry powder inhaler drug carrier
IT8822379A0 (en) ORAL PHARMACEUTICAL FORMULATIONS WITH SELECTIVE DELIVERY INTO THE COLON.
FI972646A0 (en) Piperazine derivatives, these compounds containing drugs, their use and process for their preparation
FI933942A (en) Cyclic urea derivatives
FI954115A (en) Seal for a medicine container
ATA903696A (en) ELECTRO TRANSPORT MEDICINE ADMINISTRATION
DE69617431D1 (en) MEDICINE POWDER CARTRIDGE WITH INTEGRATED DOSING DEVICE AND POWDER INHALATOR
DE68901494D1 (en) COMPOSITIONS WITH DELAYED DELIVERIES OF ACTIVE SUBSTANCES.
KR950700754A (en) New drugs (NOVEL MEDICAMENT)
FI93214B (en) Process and intermediate for the preparation of 0- (3-amino-2-hydroxypropyl) hydroxyiminic acid halides useful as a drug
FI103050B1 (en) Process for the preparation of a composition containing N, O-sulfated heparosans
EE03111B1 (en) Glucocorticosteroid epimers, processes for their preparation and pharmaceutical preparations containing them
FI951710A (en) Procedure for Determining the Concentration of a Brief Substance Containing a Tracer in a Solution of Active Substances
IL94806A0 (en) Pharmaceutical preparation containing thiol derivatives together with other active compounds
NO982874D0 (en) Pharmaceutical preparations with vitamin D analogues
EE04348B1 (en) Carbohydrate derivatives, a pharmaceutical composition containing them and their use
EE9400070A (en) Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and a process for their preparation
NO942215D0 (en) Urea derivatives containing a heterocyclic ring
HUP0101131A3 (en) Anti-inflammatory dihydrobenzopyran derivatives, medicaments containing the same, and their use
ATE63215T1 (en) DIVIDEABLE CAPSULE.
FI963683A0 (en) Use of dimeticone as a transport and carrier system and / or a drug delivery system
EE04347B1 (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, medicament and pharmaceutical composition containing them

Legal Events

Date Code Title Description
FD Application lapsed